Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation

Annals of Hematology

Volumn 92, Issue 1, 2013, Pages 121-123

  Mian, Michael ^a   Farsad, Mohsen ^a   Pescosta, Norbert ^a   Casini, Marco ^a   Cavattoni, Irene Maria ^a   Deola, Sara ^a   Cortelazzo, Sergio ^a  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENDAMUSTINE; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CLASSICAL HODGKIN LYMPHOMA; DONOR LYMPHOCYTE INFUSION; DRUG DOSE ESCALATION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; LETTER; LUNG METASTASIS; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; REDUCED INTENSITY CONDITIONING; SALVAGE THERAPY; TOXIC HEPATITIS; TUMOR VOLUME;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DACARBAZINE; DEOXYCYTIDINE; DOXORUBICIN; DRUG-INDUCED LIVER INJURY; ETOPOSIDE; FATAL OUTCOME; FEMALE; GRAFT VS HOST DISEASE; HODGKIN DISEASE; HUMANS; IFOSFAMIDE; MALE; NITROGEN MUSTARD COMPOUNDS; PREDNISOLONE; PREDNISONE; PROCARBAZINE; RECURRENCE; REOPERATION; SALVAGE THERAPY; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; VINBLASTINE; VINCRISTINE; YOUNG ADULT;

EID: 84872313502     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1525-z     Document Type: Letter

References (10)

1. Wudhikarn K, Brunstein CG, Bachanova V, Burns LJ, Cao Q, Weisdorf DJ (2011) Relapse of lymphoma after allogeneic hematopoietic cell transplantation: management strategies and outcome. Biol Blood Marrow Transplant 17(10):1497-1504. doi: 10.1016/j.bbmt.2011.02.009
2. Gopal AK, Ramchandren R, O'Connor OA, Berryman RB, Advani RH, Chen R, Smith SE, Cooper M, Rothe A, Matous JV, Grove LE, Zain J (2012) Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplant. Blood. doi: 10.1182/blood-2011-12-397893
3. Magyari F, Simon Z, Barna S, Udvardy M, Varoczy L, Illes A (2011) Successful administration of rituximab-bendamustine regimen in the relapse of Hodgkin lymphoma after autologous hemopoietic stem cell transplantation. Hematol Oncol. doi: 10.1002/hon.1004
4. D'Elia GM, De Angelis F, Breccia M, Annechini G, Panfilio S, Danieli R, Cavalieri E, Pulsoni A (2010) Efficacy of bendamustine as salvage treatment in an heavily pre-treated Hodgkin lymphoma. Leuk Res 34(11):e300-301. doi: 10.1016/j.leukres.2010.06.011
5. Moskowitz AJ, Hamlin PA Jr, Gerecitano J, Horwitz SM, Matasar M, Meikle J, Noy A, Palomba ML, Portlock CS, Straus DJ, Vanak JM, Zelenetz AD, Moskowitz CH (2009) Bendamustine is highly active in heavily pre-treated relapsed and refractory Hodgkin lymphoma and serves as a bridge to allogeneic stem cell transplant. ASH Annu Meet Abstr 114(22):720
6. Bartlett NL, Rosenberg SA, Hoppe RT, Hancock SL, Horning SJ (1995) Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report. J Clin Oncol 13(5):1080-1088
7. Santoro A, Magagnoli M, Spina M, Pinotti G, Siracusano L, Michieli M, Nozza A, Sarina B, Morenghi E, Castagna L, Tirelli U, Balzarotti M (2007) Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma. Haematologica 92(1):35-41
8. Diehl V, Sieber M, Ruffer U, Lathan B, Hasenclever D, Pfreundschuh M, Loeffler M, Lieberz D, Koch P, Adler M, Tesch H (1997) BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's lymphoma study group. Ann Oncol 8(2):143-148
9. Bonadonna G, Zucali R, Monfardini S, De Lena M, Uslenghi C (1975) Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP. Cancer 36(1):252-259
10. Engel C, Loeffler M, Schmitz S, Tesch H, Diehl V (2000) Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's lymphoma study group (GHSG). Ann Oncol 11(9):1105-1114